United Kingdom Immuno-oncology Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2028

1.     Report Overview

1.1.  Report Description

1.2.  Research Methods

1.3.  Research Approaches

2.     Executive Summary

3.     Market Overview

3.1.  Introduction

3.2.  Market Dynamics

3.2.1.     Drivers

3.2.2.     Restraints

3.2.3.     Opportunities

3.2.4.     Challenges

3.3.  PEST-Analysis

3.4.  Porter's Diamond Model for the United Kingdom Immuno-oncology Market

3.5.  IGR-Growth Matrix Analysis

3.6.  Competitive Landscape in the United Kingdom Immuno-oncology Market

4.     United Kingdom Immuno-oncology Market by Type

4.1.  Immune Cell Therapy

4.2.  Monoclonal Antibodies

4.3.  Checkpoint Inhibitors

4.4.  Cytokines

4.5.  Cancer Vaccines

4.6.  Others

5.     United Kingdom Immuno-oncology Market by Targets

5.1.  LAG-3

5.2.  Anti-CTLA-4

5.3.  MAGE-A3

5.4.  VEGF

5.5.  HDAC

5.6.  Others

6.     United Kingdom Immuno-oncology Market by Indication

6.1.  Malignant Tumors

6.2.  Benign Tumors

6.3.  Others

7.     United Kingdom Immuno-oncology Market by End Users

7.1.  Hospitals

7.2.  Specialty Clinics

7.3.  Others

8.     Company Profiles

8.1.  Company 1

8.2.  Company 2

8.3.  Company 3

8.4.  Company 4

8.5.  Company 5